Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston to acquire Remon

This article was originally published in Clinica

Executive Summary

Boston Scientific is set to acquire Israeli wireless technology specialist Remon Medical Technologies. The deal, which is expected to close by the end of the third quarter, will combine Remon's miniature intra-body monitoring implants with Boston's cardiac rhythm management product line, in a bid to boost post-operative monitoring, nerve and tissue stimulation, local drug delivery, and drug development. Remon houses the RemonCHF (congestive heart failure) monitoring system for looking at patients' hemodynamic status, and the RemonAAA (abdominal aortic aneurysm) post-operative monitoring system for examining pressure, following an endograft procedure. Details of the acquisition were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048986

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel